CD274 and neoplasm: These results suggest that high PD-L1 expression is associated with a more favorable prognosis, consistent with previous studies showing that patients with elevated PD-L1 expression in tumor cells exhibit greater sensitivity to PD-1/PD-L1 inhibitors and achieve improved treatment outcomes (19–23).